VYNE Therapeutics (VYNE) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-3.24
-2.21
-1.18
-0.15

Details

Expected EPS
-2.61
Actual EPS
-1.48
Surprise EPS
1.13
Surprise Percent
+43.3%

Description

VYNE Therapeutics (VYNE) has reported earnings of -1.48 per share for Q1 2023.

0 Comments

Share your thoughts